We are live on ! Find out more
HPC

HM Payson & Co Portfolio holdings

AUM $7.54B
1-Year Est. Return 31.34%
This Fund
S&P 500
This Quarter Est. Return
+10.72%
1 Year Est. Return
+31.34%
3 Year Est. Return
+94.39%
5 Year Est. Return
+124.39%
10 Year Est. Return
+419.98%
AUM
$4.83B
AUM Growth
+$563M
Cap. Flow
+$144M
Cap. Flow %
2.98%
Top 10 Hldgs %
35.17%
Holding
1,061
New
61
Increased
122
Reduced
336
Closed
98

Top Sells

Rank Stock Value
1
OTIS icon
Otis Worldwide
OTIS
+$42.9M
2
TSM icon
TSMC
TSM
+$32.1M
3
LPLA icon
LPL Financial
LPLA
+$30.1M
4
HON icon
Honeywell
HON
+$20.6M
5
PII icon
Polaris
PII
+$19.4M

Sector Composition

Rank Sector Weight
1 Technology 32.36%
2 Healthcare 13.82%
3 Financials 12.93%
4 Consumer Discretionary 9.38%
5 Industrials 7.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.8T
$333M 6.9%
1,729,323
+87,511
+5% +$16.2M
MSFT icon
2
Microsoft
MSFT
$2.99T
$297M 6.14%
788,770
+29,893
+4% +$10.6M
GOOG icon
3
Alphabet (Google) Class C
GOOG
$4.29T
$199M 4.12%
1,411,226
+156,664
+12% +$21.3M
AVGO icon
4
Broadcom
AVGO
$1.8T
$183M 3.78%
1,635,790
-39,860
-2% -$3.77M
BRK.B icon
5
Berkshire Hathaway Class B
BRK.B
$1.06T
$137M 2.84%
384,549
-6,735
-2% -$2.36M
JNJ icon
6
Johnson & Johnson
JNJ
$599B
$119M 2.47%
759,394
-20,994
-3% -$3.22M
BILS icon
7
State Street SPDR Bloomberg 3-12 Month T-Bill ETF
BILS
$3.84B
$116M 2.4%
1,170,653
+187,081
+19% +$18.6M
ACN icon
8
Accenture
ACN
$88.6B
$106M 2.19%
301,814
+33,903
+13% +$10.9M
V icon
9
Visa
V
$686B
$105M 2.17%
401,921
+57,531
+17% +$14.2M
MA icon
10
Mastercard
MA
$484B
$105M 2.17%
245,167
+18,322
+8% +$7.36M
CDW icon
11
CDW
CDW
$16.6B
$98.9M 2.05%
435,155
-9,737
-2% -$2.06M
LRCX icon
12
Lam Research
LRCX
$384B
$96.1M 1.99%
1,226,310
-27,650
-2% -$1.88M
HD icon
13
Home Depot
HD
$332B
$94.4M 1.95%
272,295
-43,024
-14% -$13.3M
MCD icon
14
McDonald's
MCD
$190B
$91.4M 1.89%
308,186
-1,039
-0.3% -$283K
ABBV icon
15
AbbVie
ABBV
$448B
$88.1M 1.82%
568,583
+25,316
+5% +$3.69M
UNH icon
16
UnitedHealth
UNH
$383B
$81.1M 1.68%
154,131
+1,419
+0.9% +$757K
AME icon
17
Ametek
AME
$53.9B
$79.3M 1.64%
480,863
+23,960
+5% +$3.65M
TMO icon
18
Thermo Fisher Scientific
TMO
$196B
$76.8M 1.59%
144,764
-1,113
-0.8% -$539K
GOOGL icon
19
Alphabet (Google) Class A
GOOGL
$4.3T
$75.5M 1.56%
540,219
-12,074
-2% -$1.62M
MPC icon
20
Marathon Petroleum
MPC
$92.1B
$65.3M 1.35%
440,451
+24,753
+6% +$3.68M
SPGI icon
21
S&P Global
SPGI
$133B
$63M 1.31%
143,123
-1,817
-1% -$717K
MRK icon
22
Merck
MRK
$307B
$62.2M 1.29%
570,524
+46,666
+9% +$4.84M
AZO icon
23
AutoZone
AZO
$48.9B
$58.7M 1.22%
22,700
+8,580
+61% +$22.3M
HPQ icon
24
HP
HPQ
$22.1B
$58.3M 1.21%
1,936,972
+186,244
+11% +$5.22M
IBDP
25
DELISTED
iShares iBonds Dec 2024 Term Corporate ETF
IBDP
$58.2M 1.2%
2,334,722
+395,877
+20% +$9.81M

Similar funds

HM Payson & Co's Q4 2023 Portfolio in Review

As of Q4 2023, HM Payson & Co held 1,061 positions worth $4.83B, up 13% from $4.27B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

HM Payson & Co's Q4 2023 filing shows 61 new, 122 increased, 336 reduced and 98 closed positions. Its largest new stake was iShares iBonds Dec 2024 Term Treasury ETF: 2,201,207 shares worth $52.5M. The largest sale was Otis Worldwide, an estimated $42.9M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 29% a quarter earlier, followed by Healthcare and Financials.

  • HM Payson & Co's largest Q4 2023 buy was iShares iBonds Dec 2024 Term Treasury ETF: 2,201,207 shares worth $52.5M.
  • HM Payson & Co added most to ASML in Q4 2023, an estimated $43.7M increase.
  • HM Payson & Co's biggest Q4 2023 reduction was Otis Worldwide, cutting an estimated $42.9M.
  • HM Payson & Co fully exited Invesco BulletShares 2023 Corporate Bond ETF in Q4 2023, selling an estimated $3.97M.
  • HM Payson & Co's ten largest holdings make up 35% of its $4.83B portfolio in Q4 2023.
  • HM Payson & Co opened 61 new positions and closed 98 in Q4 2023.
  • HM Payson & Co's portfolio value rose 13% quarter-over-quarter to $4.83B.

Based on HM Payson & Co's 13F filing for Q4 2023, filed 13 Feb 2024.